Patricia Ann Duffy

Array ( [id] => 4138028 [patent_doc_number] => 06060277 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Human AFC1' [patent_app_type] => 1 [patent_app_number] => 9/022699 [patent_app_country] => US [patent_app_date] => 1998-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10754 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060277.pdf [firstpage_image] =>[orig_patent_app_number] => 022699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531845 [patent_doc_number] => 06410263 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Histidine kinase' [patent_app_type] => B1 [patent_app_number] => 09/015189 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12505 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410263.pdf [firstpage_image] =>[orig_patent_app_number] => 09015189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308645 [patent_doc_number] => 06316218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Intestinal trefoil proteins' [patent_app_type] => 1 [patent_app_number] => 9/056868 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6762 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316218.pdf [firstpage_image] =>[orig_patent_app_number] => 056868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4120625 [patent_doc_number] => 06072032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'FtsY polypeptides from Streptococcus pneumoniae' [patent_app_type] => 1 [patent_app_number] => 9/007484 [patent_app_country] => US [patent_app_date] => 1998-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12111 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/072/06072032.pdf [firstpage_image] =>[orig_patent_app_number] => 007484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171761 [patent_doc_number] => 06083748 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Antibodies which specifically bind to a novel .kappa./.mu.-like protein tyrosineospatase, PTP.lambda., and hybridoma cell lines producing the same' [patent_app_type] => 1 [patent_app_number] => 8/991953 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 37 [patent_no_of_words] => 32936 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083748.pdf [firstpage_image] =>[orig_patent_app_number] => 991953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079925 [patent_doc_number] => 06054294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Nucleic acid molecules encoding the neurotrophic factor NNT-1' [patent_app_type] => 1 [patent_app_number] => 8/988819 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20662 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054294.pdf [firstpage_image] =>[orig_patent_app_number] => 988819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565192 [patent_doc_number] => 06376205 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Screening methods for agents that modulate or inhibit tau association with tau or map2' [patent_app_type] => B1 [patent_app_number] => 08/913915 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 38 [patent_no_of_words] => 16016 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376205.pdf [firstpage_image] =>[orig_patent_app_number] => 08913915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939416 [patent_doc_number] => 05989820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Polynucleotides encoding a human adipophilin protein homolog' [patent_app_type] => 1 [patent_app_number] => 8/989925 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21205 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989820.pdf [firstpage_image] =>[orig_patent_app_number] => 989925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947702 [patent_doc_number] => 05955317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Antibodies to .beta.-amyloids or their derivatives and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/986948 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 25259 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955317.pdf [firstpage_image] =>[orig_patent_app_number] => 986948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577620 [patent_doc_number] => 06448036 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'ribB' [patent_app_type] => B1 [patent_app_number] => 08/977866 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12631 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448036.pdf [firstpage_image] =>[orig_patent_app_number] => 08977866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607678 [patent_doc_number] => 07098036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'Antibodies to lipoproteins and apolipoproteins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 08/970045 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18930 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098036.pdf [firstpage_image] =>[orig_patent_app_number] => 08970045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4189943 [patent_doc_number] => 06130048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Method of diagnosing Alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/966756 [patent_app_country] => US [patent_app_date] => 1997-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4650 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130048.pdf [firstpage_image] =>[orig_patent_app_number] => 966756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4061444 [patent_doc_number] => 05866370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Aminopeptidase' [patent_app_type] => 1 [patent_app_number] => 8/964631 [patent_app_country] => US [patent_app_date] => 1997-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13626 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866370.pdf [firstpage_image] =>[orig_patent_app_number] => 964631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3981969 [patent_doc_number] => 05861281 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Lacc' [patent_app_type] => 1 [patent_app_number] => 8/961539 [patent_app_country] => US [patent_app_date] => 1997-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12648 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861281.pdf [firstpage_image] =>[orig_patent_app_number] => 961539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931283 [patent_doc_number] => 05928882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Treatment and prevention of neurodegenerative diseases using modulators of Fe65' [patent_app_type] => 1 [patent_app_number] => 8/957660 [patent_app_country] => US [patent_app_date] => 1997-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3892 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928882.pdf [firstpage_image] =>[orig_patent_app_number] => 957660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335308 [patent_doc_number] => 06593114 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Staphylococcus aureus polynucleotides and sequences' [patent_app_type] => B1 [patent_app_number] => 08/956171 [patent_app_country] => US [patent_app_date] => 1997-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 77682 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593114.pdf [firstpage_image] =>[orig_patent_app_number] => 08956171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323547 [patent_doc_number] => 06329168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Streptococcus pneumoniae isoleucyl tRNA synthetase' [patent_app_type] => 1 [patent_app_number] => 8/953040 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16470 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329168.pdf [firstpage_image] =>[orig_patent_app_number] => 953040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303966 [patent_doc_number] => 06251872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Nucleic acid vaccines for ehrlichia chaffeensis and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/953326 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11641 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251872.pdf [firstpage_image] =>[orig_patent_app_number] => 953326 [rel_patent_id] =>[rel_patent_doc_number] =>)